Avon protection from COVID-19

Avon (LON: AVON) won new contracts during the first half but they will probably not make much of a contribution in the six months to March 2020. The long-term outlook is positive, and the share price is more than one-quarter higher than at the start of the year.

All Avon’s factories appear to have stayed open and are producing normally with no indicated problems due to COVID-19.

Contracts have been won to supply side protection body armour plates and small arms protection inserts for the US. The former has a minimum value of $19m over an initial 18 months, although it could be worth a lot more, and the latter is worth $20m with deliveries starting in 2021.

There is also a $21m M69 aircrew mask order. Deliveries are starting this year.
Interims
Body armour and protection sales wi...

Previous articleInternational potential for DCC
Next articleFTSE 100 soars on vaccine hopes
Andrew Hore is the publisher of AIM Journal, which is an online monthly publication covering the Alternative Investment Market.